[HTML][HTML] Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy

X Zhang, Y Hu, P Cheng, H Zhou, X Chen… - … journal of medical …, 2021 - ncbi.nlm.nih.gov
Intervertebral disc (IVD) degeneration (IDD) is a multifactorial pathological process
associated with low back pain (LBP). The pathogenesis is complicated, and the main …

Role of caspase family in intervertebral disc degeneration and its therapeutic prospects

L Li, J He, G Zhang, H Chen, Z Luo, B Deng, Y Zhou… - Biomolecules, 2022 - mdpi.com
Intervertebral disc degeneration (IVDD) is a common musculoskeletal degenerative disease
worldwide, of which the main clinical manifestation is low back pain (LBP); approximately …

Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis

Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu… - Journal of …, 2021 - Springer
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …

[HTML][HTML] Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration

Y Peng, X Qing, H Shu, S Tian, W Yang… - Biomaterials …, 2021 - ncbi.nlm.nih.gov
Low back pain is a vital musculoskeletal disease that impairs life quality, leads to disability
and imposes heavy economic burden on the society, while it is greatly attributed to …

Non-enzymatic glycation increases the failure risk of annulus fibrosus by predisposing the extrafibrillar matrix to greater stresses

M Zhou, ES Archibeck, Y Feteih, Y Abubakr… - Acta Biomaterialia, 2023 - Elsevier
Growing clinical evidence suggests a correlation between diabetes and more frequent and
severe intervertebral disc failure, partially attributed to accelerated advanced glycation end …

[HTML][HTML] Melatonin-loaded self-healing hydrogel targets mitochondrial energy metabolism and promotes annulus fibrosus regeneration

X Hu, X Tian, C Yang, F Ling, H Liu, X Zhu, M Pei… - Materials Today Bio, 2023 - Elsevier
Intervertebral disc (IVD) herniation is a major cause of chronic low back pain and disability.
The current nucleus pulposus (NP) discectomy effectively relieves pain symptoms, but the …

Understanding the etiopathogenesis of lumbar intervertebral disc herniation: From clinical evidence to basic scientific research

M Zhou, AA Theologis, GD O'Connell - JOR spine, 2024 - Wiley Online Library
Lumbar intervertebral disc herniation, as a leading cause of low back pain, productivity loss,
and disability, is a common musculoskeletal disorder that results in significant …

[HTML][HTML] Regulated cell death: implications for intervertebral disc degeneration and therapy

F Yang, W Liu, Y Huang, S Yang, Z Shao, X Cai… - Journal of Orthopaedic …, 2022 - Elsevier
As a controllable biological process, regulated cell death (RCD) extensively participates in
cellular homeostasis, organismal development, and the pathogenesis of diseases. This …

[HTML][HTML] The potential role of cytokines in diabetic intervertebral disc degeneration

S Li, C Huang, J Xiao, Y Wu, Z Zhang, Y Zhou… - Aging and …, 2022 - ncbi.nlm.nih.gov
Intervertebral disc degeneration (IVDD) is a major cause of low back pain. Diabetes mellitus
is a chronic inflammatory disease that may cause or aggravate IVDD; however, the …

Hesperidin mitigates oxidative stress-induced ferroptosis in nucleus pulposus cells via Nrf2/NF-κB axis to protect intervertebral disc from degeneration

J Zhu, R Sun, C Yan, K Sun, L Gao, B Zheng, J Shi - Cell Cycle, 2023 - Taylor & Francis
Intervertebral disc degeneration (IVDD), a widely known contributor to low back pain (LBP),
has been proved to be a global health challenging conundrum. Hesperidin (hesperetin-7-O …